Page last updated: 2024-12-04

4-aminobutyraldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-aminobutanal : An omega-aminoaldehyde that is butanal in which one of the hydrogens of the terminal methyl group has been replaced by an amino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID118
CHEMBL ID2261442
CHEBI ID17769
MeSH IDM0049114

Synonyms (21)

Synonym
CHEBI:17769 ,
butyraldehyde, 4-amino-
butanal, 4-amino- (9ci)
butyraldehyde, 4-amino- (6ci,7ci,8ci)
butanal, 4-amino-
4-AMINO-BUTYRALDEHYDE ,
gamma-aminobutyraldehyde
4390-05-0
C02903
4-aminobutanal
4-aminobutyraldehyde
C00555
AKOS006338849
CHEMBL2261442
gtpl6606
4-amino-butanal
DZQLQEYLEYWJIB-UHFFFAOYSA-N
Q27073754
DTXSID50863389
PD049909
EN300-7572104

Research Excerpts

Effects

ExcerptReferenceRelevance
"4-Aminobutyraldehyde (ABAL) has been shown to cross the blood-brain barrier and to be converted rapidly to gamma-aminobutyric acid (GABA) in various regions of the brain. "( Conversion of 4-aminobutyraldehyde to gamma-aminobutyric acid in striatum treated with semicarbazide and kainic acid.
Hori, S; Matsuda, M; Matsushima, S, 1986
)
2.07
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
aminobutanalAny member of the class of butanals carrying by at least one amino group on the butanal skeleton.
omega-aminoaldehydeAn amino aldehyde that is an aliphatic aldehyde in which one of the hydrogens of the terminal methyl group has been replaced by an amino group. H2NCH2(CH2)nCHO, where n = 0, 1, 2, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
Arginine Metabolism2848
Ornithine Metabolism1631
Arginine and Proline metabolism ( Arginine and Proline metabolism )4255
superpathway of arginine and ornithine degradation027
superpathway of arginine, putrescine, and 4-aminobutyrate degradation026
Biosynthesis of gamma-aminobutyric acid (GABA) by polyamine oxidation05
Biochemical pathways: part I0466
Beta-alanine biosynthesis I312

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (40.63)18.7374
1990's13 (40.63)18.2507
2000's1 (3.13)29.6817
2010's4 (12.50)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.11 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index27.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]